GE HealthCare Technologies Inc. GEHC

66.63 0.25 0.38% as of 25 Sep
Market cap
$29.9B
P/E
15.3×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

GE HealthCare Technologies Inc. (GEHC) Revenue growth

GE HealthCare Technologies Inc.'s revenue growth over the twelve months to 30 June 2026 was 6.51%, up 1.7 percentage points from fiscal 2025 (4.84%). Over the past ten years it has ranged from 0.61% (fiscal 2024) to 6.60% (fiscal 2023); the current reading is higher than 83% of that period. That is below the Medical Devices industry median of 8.80% and below the Healthcare sector median of 8.26%.

Revenue growth, annual

Annual

Period Revenue growth Change (points)
FY2025 4.84% 4.23
FY2024 0.61% (5.99)
FY2023 6.60% 2.30
FY2022 4.30% 1.85
FY2021 2.45% (0.74)
FY2020 3.19% —

Quarterly

Period Revenue growth Change (points)
Jun 2026 5.75% (1.66)
Mar 2026 7.41% 0.30
Dec 2025 7.11% 1.35
Sep 2025 5.76% 2.29
10 more quarters

Against its own ten years

Low 0.61% High 6.60%
Ten-year median 3.75%
Current reading's percentile 83

Revenue growth against peers

Company Revenue growth
PEN Penumbra, Inc. compare 17.6%
DXCM DexCom, Inc. compare 15.5%
EW Edwards Lifesciences Corporation compare 14.6%
BSX Boston Scientific Corporation compare 13.5%
PHG Koninklijke Philips N.V. compare 9.11%
ZBH Zimmer Biomet Holdings, Inc. compare 8.62%
STE STERIS plc compare 8.37%
GEHC GE HealthCare Technologies Inc. 6.51%
SNN Smith & Nephew SNATS, Inc. compare 4.81%
Medical Devices industry median 8.80%
Healthcare sector median 8.26%
Market median 7.41%

What Revenue growth is

Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.

(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|

The full definition of Revenue growth →

More on GEHC